ARTICLE | Clinical News
CXA-201: Phase II started
July 12, 2010 7:00 AM UTC
Cubist began a double-blind, international Phase II trial to compare CXA-201 plus metronidazole vs. meropenem plus placebo in 120 patients. Astellas Pharma Inc. (Tokyo:4503, Tokyo, Japan) granted wor...